(Story updated to include stock move in the headline and last paragraph.) Geron (GERN) reported a Q2 net loss of $0.07 per diluted share late Thursday,...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Geron (GERN) reported a Q2 net loss of $0.07 per diluted share late Thursday, compared with a loss of $0.09 per share a year earlier. Analysts polled by...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
VERU gains on the success of its late stage study evaluating the efficacy and safety of oral...
| Address | 919 East Hillsdale Boulevard Foster City, California 94404 |
| Phone | +1.650.473.7700 |
| Number of Employees | 17 |
| Recent SEC Filing | 08/11/2022 S-8 |
| Chairman, President & Chief Executive Officer | John A. Scarlett |
| Chief Operating Officer & Executive Vice President | Andrew J. Grethlein |
| Chief Financial Officer, Treasurer & Executive VP | Olivia K. Bloom |
| Chief Medical Officer & Executive Vice President | Faye Feller |
| Price Open | $2.36 |
| Previous Close | $2.35 |
| 52 Week Range | $0.99 - 2.67 |
| Market Capitalization | $891.7 M |
| Shares Outstanding | 377.8 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 11/08/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$0.34 |
| Beta vs. S&P 500 | N/A |
| Revenue | $1.1 M |
| Net Profit Margin | -8,693.61% |
| Return on Equity | -90.38% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
